Shelley Thunen B.'s most recent trade in LENZ Therapeutics Inc. was a trade of 13,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENZ Therapeutics Inc. | Shelley B. Thunen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 14 Apr 2025 | 7,792 | 38,354 | - | 4.3 | 33,806 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 6,405 | 0 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 1,387 | 0 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Oct 2024 | 15,000 | 45,443 | - | 16 | 240,000 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 15,000 | 83,367 | - | - | Stock option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Sale of securities on an exchange or to another person at price $ 48.69 per share. | 01 Oct 2024 | 9,521 | 30,721 | - | 48.7 | 463,560 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Sale of securities on an exchange or to another person at price $ 47.96 per share. | 01 Oct 2024 | 5,201 | 40,242 | - | 48.0 | 249,422 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Sale of securities on an exchange or to another person at price $ 49.45 per share. | 01 Oct 2024 | 278 | 30,443 | - | 49.4 | 13,747 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 15 Jul 2024 | 16,505 | 30,443 | - | 4.3 | 71,632 | Common Stock |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 11,235 | 6,405 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 5,270 | 1,387 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.60 per share. | 01 Jul 2024 | 10,000 | 23,938 | - | 15.6 | 155,983 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 10,000 | 36,805 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.41 per share. | 01 Jul 2024 | 8,146 | 15,792 | - | 58.4 | 475,785 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.55 per share. | 01 Jul 2024 | 6,599 | 1,803 | - | 58.5 | 386,366 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.48 per share. | 01 Jul 2024 | 1,854 | 13,938 | - | 59.5 | 110,270 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.56 per share. | 01 Jul 2024 | 1,803 | 0 | - | 59.6 | 107,394 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.60 per share. | 01 May 2024 | 10,247 | 23,938 | - | 15.6 | 159,836 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,000 | 46,805 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 52.68 per share. | 01 May 2024 | 9,620 | 14,318 | - | 52.7 | 506,759 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 53.04 per share. | 01 May 2024 | 380 | 13,938 | - | 53.0 | 20,154 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.81 per share. | 01 Apr 2024 | 8,938 | 9,807 | - | 49.8 | 445,225 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.81 per share. | 01 Apr 2024 | 8,857 | 19,545 | - | 49.8 | 441,207 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.27 per share. | 01 Apr 2024 | 800 | 18,745 | - | 50.3 | 40,218 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 01 Apr 2024 | 662 | 9,145 | - | 50.2 | 33,258 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.50 per share. | 01 Apr 2024 | 543 | 8,402 | - | 51.5 | 27,965 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.37 per share. | 01 Apr 2024 | 200 | 8,945 | - | 50.4 | 10,074 | Common Stock |
| LENZ Therapeutics Inc. | Shelley B. Thunen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 92,200 | 92,200 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.60 per share. | 01 Mar 2024 | 10,000 | 23,691 | - | 15.6 | 155,983 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 10,000 | 56,805 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.38 per share. | 01 Mar 2024 | 6,361 | 16,164 | - | 56.4 | 358,618 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.03 per share. | 01 Mar 2024 | 2,473 | 13,691 | - | 57.0 | 141,042 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 54.95 per share. | 01 Mar 2024 | 1,166 | 22,525 | - | 54.9 | 64,066 | Common Stock |
| RxSight Inc | B. Shelley Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 15,875 | 95,000 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen Shelley B. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.95 per share. | 05 Feb 2024 | 15,875 | 29,566 | - | 14.9 | 237,331 | Common Stock |
| RxSight Inc | Shelley Thunen B. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.47 per share. | 05 Feb 2024 | 15,875 | 13,691 | - | 47.5 | 753,574 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.95 per share. | 05 Feb 2024 | 9,125 | 22,816 | - | 15.0 | 136,419 | Common Stock |
| RxSight Inc | Shelley Thunen B. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 9,125 | 110,875 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen Shelley B. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.02 per share. | 05 Feb 2024 | 9,125 | 13,691 | - | 47.0 | 429,087 | Common Stock |
| RxSight Inc | Thunen B. Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 6,900 | 17,640 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen Shelley B. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 05 Feb 2024 | 6,900 | 13,691 | - | 4.3 | 29,946 | Common Stock |
| RxSight Inc | Thunen B. Shelley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.11 per share. | 26 Jan 2024 | 31,772 | 6,791 | - | 47.1 | 1,496,706 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 31,772 | 16,629 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen B. Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.08 per share. | 26 Jan 2024 | 31,772 | 38,563 | - | 15.1 | 479,122 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 4,500 | 24,540 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen Shelley B. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.34 per share. | 26 Jan 2024 | 4,500 | 6,791 | - | 4.3 | 19,530 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.60 per share. | 02 Jan 2024 | 10,000 | 12,291 | - | 15.6 | 155,983 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 10,000 | 66,805 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Thunen Shelley B. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.63 per share. | 02 Jan 2024 | 5,481 | 2,291 | - | 39.6 | 217,218 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.77 per share. | 02 Jan 2024 | 4,519 | 7,772 | - | 38.8 | 175,191 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.35 per share. | 15 Dec 2023 | 20,000 | 2,291 | - | 39.3 | 786,984 | Common Stock |
| RxSight Inc | B. Shelley Thunen | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.60 per share. | 15 Dec 2023 | 20,000 | 22,291 | - | 15.6 | 312,000 | Common Stock |
| RxSight Inc | B. Thunen Shelley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 20,000 | 76,805 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley Thunen B. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 15 Dec 2023 | 10,000 | 38,402 | - | 39.3 | 393,120 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.32 per share. | 15 Dec 2023 | 10,000 | 28,402 | - | 39.3 | 393,206 | Common Stock |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Shelley B. Thunen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2021 | 98,367 | 98,367 | - | - | Stock option (right to buy) |